Treatment of severe pulmonary hypertension in patients with interstitial lung disease: Results in 72 patients from the “HYPID” prospective study
V. Cottin, D. Montani, M. Reynaud-Gaubert, L. Kiakouama, H. Nunes, C. Dromer, B. Wallaert, C. Gomez, S. Quetant, D. Launay, E. Gomez, L. Bertoletti, J. Traclet, S. Polazzi, S. Zeghmar, A. M. Schott, M. Humbert, J. F. Cordier (Lyon, Paris, Marseille, Bobigny, Bordeaux, Lille, Grenoble, Nancy, Saint-Etienne, France)
Source: Annual Congress 2013 –Pulmonary circulation: treatment
Session: Pulmonary circulation: treatment
Session type: Oral Presentation
Number: 1782
Disease area: Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Cottin, D. Montani, M. Reynaud-Gaubert, L. Kiakouama, H. Nunes, C. Dromer, B. Wallaert, C. Gomez, S. Quetant, D. Launay, E. Gomez, L. Bertoletti, J. Traclet, S. Polazzi, S. Zeghmar, A. M. Schott, M. Humbert, J. F. Cordier (Lyon, Paris, Marseille, Bobigny, Bordeaux, Lille, Grenoble, Nancy, Saint-Etienne, France). Treatment of severe pulmonary hypertension in patients with interstitial lung disease: Results in 72 patients from the “HYPID” prospective study. Eur Respir J 2013; 42: Suppl. 57, 1782
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: